CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,706 shares at $7.63 ($13,017)
- 4 Open-market buy 10% owner bought 310,559 shares at $6.44 ($2,000,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SEE REMARKS sold 4,653 shares at $4.75 ($22,102)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,158 shares at $4.75 ($24,501)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 4,163 shares at $4.75 ($19,774)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 15,168 shares at $4.75 ($72,048)
- 4 Open-market sale SEE REMARKS sold 5,489 shares at $4.75 ($26,073)
- 4 Grant or award Director acquired 1,400 shares (grant or award)
- 4 Grant or award Director acquired 1,400 shares (grant or award)
- 4 Grant or award Director acquired 1,400 shares (grant or award)
- 4 Grant or award Director acquired 1,400 shares (grant or award)
- 4 Grant or award Director acquired 1,750 shares (grant or award)
- 4 Grant or award Director acquired 1,400 shares (grant or award)
- 4 Open-market sale SEE REMARKS sold 2,093 shares at $6.09 ($12,746)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 231 shares at $6.09 ($1,407)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,786 shares at $6.09 ($10,877)
- 4 Open-market sale SEE REMARKS sold 2,002 shares at $6.09 ($12,192)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,392 shares at $6.09 ($45,017)
- 4 Open-market sale SEE REMARKS sold 1,227 shares at $6.74 ($8,270)
Page 3 of 15 · 288 filings